TE_19339
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MIRb |
|---|---|
| TE superfamily | L2-end |
| TE order | SINE |
| Gene | TRAPPC9 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 176.95 |
| Counts of samples | TCGA_tumor:156; TCGA_normal:0; GTEx:0 |
| TSS | chr8(-):139919242 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_19339.1 | TRAPPC9 | Chimeric | Non-coding | Non-coding | chr8(-):139731208,139731228,139731979,139732202,139885879,139885969,139910147,139910300,139919216,139919243 |
| teRNA_19339.2 | TRAPPC9 | Chimeric | Non-coding | Non-coding | chr8(-):139732182,139732202,139885879,139885969,139910147,139910300,139919216,139919243 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
